Skip to content

GenOracle Presents: Ryan Smith at H.E.A.T Anti-Aging Congress

Saturday 20th August 1.30pm - 3pm @ H.E.A.T, Terrace Room B, The Athenee Hotel Bangkok, Thailand

The Ultimate Biohack: Reversing Aging and Improving Quality of Life with Peptide Optimization

Aging is the #1 risk factor for almost all chronic diseases and death. We know that delaying the biological aging rate by just 7 years could reduce morbidity and mortality by 50%. Since 2013, epigenetic clocks have been the best way to measure the aging process of patients. In this lecture, we will discuss these clocks, and how these objective measurements of aging have informed us of the best preventative research strategies.

One of the biggest insights from these aging biomarkers has been the success of peptides. Peptides are short chain amino acid sequences which represent the fastest growing area of pharmaceutical development. We will discuss which of these peptides look positive for age management. We wlll also discuss how peptides can be appied to other areas of health optimizations such as improvig body compostion, improvng sexual function, and more.

About Ryan Smith and TruDiagnostic™

Ryan Smith attended Transylvania University and graduated with a degree in Biochemistry. After finishing all the educational curriculum and passing USMLE Step 1 he decided to leave and open up a pharmacy in the United States that focused on peptide synthesis and formulations for pharmaceutical preparations.

That pharmacy, Tailor Made Compounding, became the 4th fastest growing company in healthcare in the US. During that time Ryan invested in several businesses in the functional medicine space. Ryan exited Tailor Made in late 2020.

Since then, Ryan has opened many businesses including TruDiagnostic, a company focusing on methylation array-based diagnostics for life extension and preventive healthcare.

TruDiagnostic is a CLIA certified lab and health data company focused on serving integrative and functional medicine providers in the United States. TruDiagnostic has a commitment to research with over 30 approved clinical research studies investigating the epigenetic methylation changes of a variety of longevity and health interventions.

Since TruDiagnostic’s inception, they have created one of the largest private epigenetic health databases in the world with over 15,000 patients tested and continues to lead the space in epigenetic methylation interpretation and diagnostic prediction.

In Association With